Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?
What if, instead of waiting for a donor cornea to become available, you could just print one?
The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.
Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.
Is gene therapy the answer to an untreatable form of macular degeneration?
Stem cells hold great promise, but is it the cells we really need?
A woman who can identify people with Parkinson’s by smell is helping scientists pinpoint molecules
Creating a ceramic “window” in the skull could provide better access to the brain
Renã Robinson, Assistant Professor, University of Pittsburgh, Pennsylvania, USA
Metal speciation in cerebrospinal fluid may bring new understanding of neurodegenerative diseases.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.